Science Current Events | Science News | Brightsurf.com
 

Add-on omalizumab quells high-risk asthma. (Clinical Rounds: Experimental anti-IgE therapy).(Brief Article): An article from: Internal Medicine News


by Miriam E. Tucker

List Price: $5.95
Available: Available for download now
Studio: International Medical News Group
Binding: Digital
Publication Date: April 01, 2002
Publisher: International Medical News Group


FORMATS

  • HTML


EDITORIAL REVIEWS

Product Description
This digital document is an article from Internal Medicine News, published by International Medical News Group on April 1, 2002. The length of the article is 608 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Add-on omalizumab quells high-risk asthma. (Clinical Rounds: Experimental anti-IgE therapy).(Brief Article)
Author: Miriam E. Tucker
Publication: Internal Medicine News (Magazine/Journal)
Date: April 1, 2002
Publisher: International Medical News Group
Volume: 35 Issue: 7 Page: 22(1)

Article Type: Brief Article

Distributed by Thomson Gale
© 2008 BrightSurf.com